![](/img/cover-not-exists.png)
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
Wallace, Daniel J, Furie, Richard A, Tanaka, Yoshiya, Kalunian, Kenneth C, Mosca, Marta, Petri, Michelle A, Dörner, Thomas, Cardiel, Mario H, Bruce, Ian N, Gomez, Elisa, Carmack, Tara, DeLozier, Amy MVolume:
392
Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(18)31363-1
Date:
July, 2018
File:
PDF, 1.05 MB
english, 2018